3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
4
Ovarian Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
1
SCLC,Extensive Stage
1
Prostatic Neoplasms, Castration-Resistant
1
Ovarian Carcinosarcoma
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Metastatic Castration-sensitive Prostate Cancer
1
Laryngeal Diseases
1
Hereditary Sensory and Autonomic Neuropathies
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Ovarian Epithelial
1
Biliary Tract Neoplasms
1
Interventions
Cyclophosphamide
4
Vincristine
3
Temozolomide
3
Magnetic Resonance Spectroscopy
3
Ifosfamide
3
Etoposide
3
Doxorubicin
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
liposomal doxorubicin
2
ivosidenib
2
cabozantinib
2
X-Rays
2
Topotecan
2
Specimen Handling
2
Radiation
2
Phantoms, Imaging
2
Nuclear Medicine Department, Hospital
2
Irinotecan
2
Eflornithine
2
Congresses as Topic
2
trifluridine tipiracil drug combination
1
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
larotrectinib
1
irinotecan sucrosofate
1
ganitumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
niraparib
×
30 days
×
Clear all
No trials found.